Detection of cystic fibrosis 1
A meeting on the cystic fibrosis protein (CFP) and its detection by isoelectric focusing also reviewed the diagnostic value of this method and that of other tests for cysticfibrosis (CF) . Diagnosisin CF largely depends on laboratory methods, all of which in some respect are unsatisfactory. These tests were seen as having four roles: diagnosis of clinically manifest cases, their prenatal detection, the recognition of carriers in CF kindreds, and population screening. Gibson & Cooke's (1959) pilocarpine test for sweat NaCI was considered first; it is still the only established diagnostic test. Though not without its difficulties (Committee report 1976 , Schwarzet al. 1977 it is 95% correct in detecting homozygotes, the highest proportion of all CF tests. It does not detect heterozygotes and is too time-consuming for anything but diagnosis in individual patients. The resultsare valid from one week of age onward and throughout childhood, until adulthood when there is an increasing overlap between CF and norma1.
Ion-specific electrodes and neutron-activation analysis had been used to measure NaCI in sweat, Saliva and fingernails. None of these simpler methods had achieved the diagnostic efficiency of the sweat test (Tamoky et al. 1976 ), but in Shwachman and Kopito's laboratory (Maugh 1978) hair analysis for raised sodium and low calcium concentrations showed promise.
Historically the next test, ciliary dyskinesis assay took several forms using rabbit tracheal expl a~ts or musselor oyster gill cilia. Adding CF serum to these preparations disrupted their normal ciliary beat. This was the origin of the concept of a CF factor; it was thought to be identical with CFP. The test detected most heterozygotes, but CFP was not the onlysubstance capable of causing dyskinesis, and the difficulties of the test now restricted it to two UK centres. One of these, the Belfast group, use it in parallel with their Proteus vulgaris agglutination test on CF serum (Nevin 1978) .
Pancreatic dysfunction was shown at birth by the abnormal compositionof meconium,especially the high albumin for which several methods were available, including the commercial BM test preparation. Immunochemical tests were thought to be preferable, but allmethodshad an appreciable rate of false negative and positive results. Two large trials (Kraemer et 01. 1977 01. , Ryleyet 01. 1979 , Reportofmecling held at theRoyal Berkshire Hospital, Reading in conjunction with the Cystic Fibrosis Research Trust, andsponsored byOIaxo Laboratories Ltd, 10May 1979. Accepted 7 September 1979 0141-Q768/80/01007HI2J$01.OO/O have confirmed the earlier results by the Cardiff workers (who were not present) that the use of the albumin: IX,-antitrypsin ratio improved the efficiency of the test. (A similar use of lactase was reported as unsuccessfu1.)
Trypsin, the main proteolytic enzyme, was considered in several contexts. Elliott's faecal trypsin screen (Crossleyet 01. 1977), conducted at 5 days of age, was reported to carry no false negative and only 1.2% false positive results.Two of the participants were independently engaged in running such surveys.and their findingswould be awaited with great interest. The interpretation of trypsin-binding to IgG (which also carries CFP), mentioned as a test with possible antenatal applications. was complicated by the role that exposure to exogenous trypsin could have played in antibody formation (Ro'meo et 01. 1978) . A recent method for serum immunoreactive trypsin (Crossleyel 01. 1979) appeared to be specific for endogenous human trypsin. CF children had high blood levels'at birth which in most cases fell to subnormal levels. M Super (Edinburgh) thought that acinar enzymes at first accumulated in the plasma since their exit via the pancreatic duct was blocked but would disappear as the pancreatic cells ceased to function. High levels persisted in children with no pancreatic involvement (25% of all cases at birth, falling to 15% by 3 months).
Serum and saliva were usedin studiesof amylase isoenzymes (Skude & Kollberg 1976 , Wolf et 01. 1976 , Doering et al. 1977 . Here published data seemed confused, and no direct experience was available, but the test was reported to be validonly from about 3yearsof age, sincethe normalamylase pattern evolvesslowly. After that, levelsin CF are low, the pancreatic component accounting for the deficiency, but with abnormal isoamylases also on record. As with trypsin, raised levelswerefound in patients without pancreatic involvement Taking Rao and Nadler's data as their starting point. L G Dann and K Blau (London) have been investigating arginine esterases. Some of these show low activity in CF serum, saliva and cell cultures; their rolein activating the kinins involved in ion transport across membranes may be central to the explanation of CF (Dann & Blau 1978) .
Recent reports (Scanlin et al. 1979 ) that a-Lfucosidase activities were low in serum from CF patients but high in their skin fibroblastscould be related to Chorr & Nadler's (1976) findingof a low t-fucose content in CF fibroblasts. It was considered that the time required for cell culture made this test unsuitable for routine use but serum estimations might be done. Similar objections applied to measuring the resistance of skin fibroblasts and amniotic fluid cells to dexamethasone, raised in CF, with some increase in heterozygotes (Breslow et al. 1978) .The test took up to five weeks, and the premature ageing of CF fibroblasts (Shapiro et al. 1979 ) could complicate interpretation.
Throughout the meeting the discussion returned to the detection of CFP by isoclectric focusing (Wilson et al. 1977) . G B Wilson (Charleston, USA) said that an abnormal protein double band with pi 8.41 appeared in homozygote CF serum and, though less clearly, in the sera ofcarriers. The disappearance of the normal pi 5.48 band was now seen as secondary and due to deficient CX2-macroglobulin (cxlM) breakdown. Wilson and Fudenberg have reported normal cxlM levels in CF, and P Starkey (Cambridge) shifted the emphasis to its enzymatic breakdown: the abnormality could be in the proteases and not in the cxlM. Dr Wilson's presentation was welcomed. lsoclectric focusing was clearly not a screening method, being timeconsuming, expensive in materials and requiring considerable expertise. Standardization was essential in order to obtain comparable results in different laboratories and would greatly be helped by the lyophilized control serum now being developed jointly by G B Wilson and Professor Nevin's group in Belfast (Tully et al. 1979) . The test gave 92% correct diagnoses in clinical cases; false results could be due to technical difficulty, the distance of the CFP from the biochemical lesion causing CF, or a postulated genetic heterogeneity of the disease (Danes et al. 1977; see also Lancet 1978) . The test also detected heterozygotes; it was thought to give 80% correct forecasts, and M d'Crawfurd (Clinical Research Centre, Harrow) quoted a similar figure for the ciliary dyskinesis method. lsoelectric focusing was seen as a confirmatory test. It involved splitting CFP from a carrier IgG, and since maternal IgG, presumably still binding its own CFP, persisted into the first year of life, it would be difficult to evaluate tests in patients aged under I year. The test appeared to be specific for CF; only monocytic leukaemia gave the pi 8.41 band in an otherwise different pattern. The question of prenatal diagnosis was a matter of future work.
CFP is bound to the constant region of the IgG heavy chain and can easily be dissociated from it. I R Young (Belfast) spoke of the work, prompted by the abnormal immunoglobulin pattern, to develop an antiserum for immunoassay of CFP. The group at the Department of Human Genetics, Edinburgh, were pursuing a similar line. Immu-nogenicity of the small CFP molecule was enhanced by coupling to IgG which would then be removed. This work was in an early stage but if successful could serve as a test for serum and -in view of similarities in behaviour between skin fibroblasts and amniotic cells in culture -on amniotic cells.
The purpose of the meeting was to review the diagnostic tests for CF. It was apparent that no one test would fulfil all diagnostic roles. Detection still depended on the sweat test, but a number of promising lines of research were now at a most interesting stage of development.
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